好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

The Landscape of Inpatient Pediatric Status Dystonicus Over 4.5 Years at The Hospital for Sick Children in Canada
Child Neurology and Developmental Neurology
P11 - Poster Session 11 (8:00 AM-9:00 AM)
6-004

To quantify the number of admissions involving status dystonicus (SD) in a large pediatric hospital. Secondary objectives were to identify the etiology of dystonia and triggers of SD, and evaluate key outcomes including transfer to ICU and complications of SD. 

Dystonia is a common movement disorder in children with neurological impairment, manifesting as repetitive twisting/abnormal postures. Various triggers (stress, pain, infections) can exacerbate dystonia. SD is the most extreme and life-threatening form of dystonia. As part of an ongoing quality improvement project, we analyzed the prevalence and outcomes of SD over the past 4.5 years at our institution. 

We performed a retrospective analysis of electronic medical records for patients with dystonia admitted to The Hospital for Sick Children from January 2020 to June 2024.  We only included children admitted with SD and excluded elective admissions. 

Over 4.5 years, there were 92 admissions for 48 unique patients with SD, an average of 20/year. Of these, 45%(41/92) had genetic/metabolic dystonia and 42%(39/92) had acquired dystonia.  A trigger for worsening dystonia was identified in 82%(75/92) of admissions, especially in children with acquired dystonia (35/39, 90%).  

Systemic complications of SD (rhabdomyolysis, respiratory dysfunction, fractures) were observed in 39%(36/92). ICU care was required in 22%(21/92) of admissions. Nine admissions resulted in emergent deep brain stimulation (DBS) for SD (12.5%), while 20 children (21.7%) had already received DBS prior to admission. Two deaths (2/48) occurred, both in patients with a genetic diagnosis. 

SD is common in pediatric hospitals and contributes to morbidity and mortality. Triggers were identified in most cases, stressing the need to assess triggers in all SD admissions. SD can occur in any child with dystonia, regardless of diagnosis, and often recurs in the same patient. SD can lead to complications or death without timely intervention, highlighting the need for appropriate treatments.

Authors/Disclosures
Lindsey Vogt, MD (Work)
PRESENTER
Dr. Vogt has nothing to disclose.
Nadia S. Al Azri, OMSB (Sickkids hospital) Dr. Al Azri has nothing to disclose.
Andrea LeBlanc-Millar, NP Mrs. LeBlanc-Millar has nothing to disclose.
Sara Breitbart, NP Ms. Breitbart has nothing to disclose.
Alfonso Fasano, MD, PhD, FAAN (Toronto Western Hospital - U of Toronto) Dr. Fasano has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. Dr. Fasano has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Fasano has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. Dr. Fasano has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boston Scientific. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbott. Dr. Fasano has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ceregate. Dr. Fasano has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Inbrain Neuroelectronics. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Syneos Health. Dr. Fasano has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Annovis. Dr. Fasano has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for CADTH. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for International Parkinson and Movement Disorders Society. The institution of Dr. Fasano has received research support from Boston Scientific. The institution of Dr. Fasano has received research support from Medtronic. The institution of Dr. Fasano has received research support from Abbvie. The institution of Dr. Fasano has received research support from Canadian Institutes of Health Research (CIHR). The institution of Dr. Fasano has received research support from Michael J Fox Foundation. The institution of Dr. Fasano has received research support from Bluerock Therapeutics. Dr. Fasano has received publishing royalties from a publication relating to health care. Dr. Fasano has a non-compensated relationship as a Medical Advisory Committee with CenteR for Advancing Neurological Innovation to Application (CRANIA) that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Medical Advisory Committee with HopeNET that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Medical Advisory Committee with International Essential Tremor Foundation that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Member with Tremor Research Group that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Co-Chair with Tremor Study Group of the IPMDS that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Vice-Chair with NPH Study Group of the IPMDS that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Vice-Chair with Industry Committee of the IPMDS that is relevant to AAN interests or activities.
George Ibrahim (The Hospital for Sick Children) George Ibrahim has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. George Ibrahim has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Synergia. George Ibrahim has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Livanova. George Ibrahim has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Synergia.
Carolina Gorodetsky, MD (Hospital for Sick Children) Dr. Gorodetsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic Inc . Dr. Gorodetsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic Inc . Dr. Gorodetsky has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medtronic Inc .